Bilan O. Li
Shanghai Key Laboratory Of Maternal Fetal Medicine
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Integrative multi-omics analysis identifies SNRPE as a key driver gene in uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion.
Journal: Frontiers in immunology
Published: March 10, 2026
Mapping immunosuppressive terrain in high-grade serous ovarian cancer: tumor-intrinsic, stromal, and spatial drivers of therapy response.
Journal: NPJ precision oncology
Published: October 14, 2025
Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer.
Journal: Frontiers in immunology
Published: October 14, 2025
The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.
Journal: Cell death & disease
Published: October 08, 2024
Enhanced Recovery After Gynaecological Surgery: Insights and Future Directions.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: September 18, 2024
Eribulin Induction of Immunogenic Cell Death (ICD): Comparison With Other Cytotoxic Agents and Temporal Relationship of ICD Biomarkers.
Journal: Anticancer research
Published: September 18, 2024
Cost-effectiveness of breast cancer gene 1 testing in prenatal screening: broader genetic considerations needed.
Journal: American journal of obstetrics and gynecology
Published: September 08, 2024
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma.
Journal: Cell death & disease
Published: August 06, 2024
Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer.
Journal: Experimental cell research
Published: February 20, 2023
Last Updated: 09/26/2026